Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.
Casale TB, Bernstein JA, Maurer M, Saini SS, Trzaskoma B, Chen H, Grattan CE, Gimenéz-Arnau A, Kaplan AP, Rosén K. Casale TB, et al. Among authors: rosen k. J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):743-50.e1. doi: 10.1016/j.jaip.2015.04.015. Epub 2015 Jun 6. J Allergy Clin Immunol Pract. 2015. PMID: 26054553 Free article. Clinical Trial.
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies.
Gimenéz-Arnau AM, Spector S, Antonova E, Trzaskoma B, Rosén K, Omachi TA, Stull D, Balp MM, Murphy T. Gimenéz-Arnau AM, et al. Among authors: rosen k. Clin Transl Allergy. 2016 Aug 18;6:32. doi: 10.1186/s13601-016-0120-0. eCollection 2016. Clin Transl Allergy. 2016. PMID: 27540466 Free PMC article.
Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
Casale TB, Win PH, Bernstein JA, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Antonova EN, Murphy T, Scarupa MD, Sofen H, Kaplan A. Casale TB, et al. Among authors: rosen k. J Am Acad Dermatol. 2018 Apr;78(4):793-795. doi: 10.1016/j.jaad.2017.10.010. Epub 2017 Oct 14. J Am Acad Dermatol. 2018. PMID: 29037993 Free article. Clinical Trial. No abstract available.
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria.
Maurer M, Kaplan A, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Casale TB. Maurer M, et al. Among authors: rosen k. J Allergy Clin Immunol. 2018 Mar;141(3):1138-1139.e7. doi: 10.1016/j.jaci.2017.10.018. Epub 2017 Nov 10. J Allergy Clin Immunol. 2018. PMID: 29132956 Clinical Trial. No abstract available.
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
Zazzali JL, Kaplan A, Maurer M, Raimundo K, Trzaskoma B, Solari PG, Antonova E, Mendelson M, Rosén KE. Zazzali JL, et al. Among authors: rosen ke. Ann Allergy Asthma Immunol. 2016 Oct;117(4):370-377.e1. doi: 10.1016/j.anai.2016.06.024. Epub 2016 Jul 14. Ann Allergy Asthma Immunol. 2016. PMID: 27424128 Free article. Clinical Trial.
693 results